Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Dana Stories

2014-04-18 12:35:28

A Dana-Farber/Boston Children's and VA Hospital/University of South Florida team created the antiviral therapy, which harnesses the power of stapled peptide and nanoparticle technologies to thwart the respiratory virus New therapies are needed to prevent and treat respiratory syncytial virus (RSV) – a potentially lethal respiratory infection that can severely affect infants, young children and the elderly. Despite a wide range of anti-RSV efforts, there are no vaccines or drugs on the...

2014-04-09 08:22:17

MAUMEE, Ohio, April 9, 2014 /PRNewswire/ -- Dana Holding Corporation (NYSE: DAN) will release its 2014 first-quarter financial results on Friday, April 25, 2014. A press release will be issued at approximately 7 a.m. EDT, followed by a conference call and webcast at 10 a.m. EDT. Members of the company's senior management team will be available at that time to discuss the results and answer related questions. Participants may listen to the audio portion of the conference call either...

2014-04-07 16:05:15

Researchers studying a rare, always fatal brain tumor in children have found several molecular alterations that drive the cancer, according to a new study from scientists at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and McGill University. The findings identify potential new targets for drug treatments. The new research could help physicians choose targeted agents with a better chance of combating pediatric high-grade astrocytomas, which are extremely difficult to...

2014-03-26 12:29:02

Comprehensive BMT(TM) will deliver an unmatched hematopoietic stem cell transplant (HSCT) data management solution for improved research and reporting SALT LAKE CITY, March 26, 2014 /PRNewswire/ -- Remedy Informatics, Inc., the leading provider of registry-based clinical informatics software for healthcare delivery and life sciences research, announced that it has been selected by the Stem Cell Transplantation program at Dana-Farber/Brigham and Women's Cancer Center to implement Comprehensive...

2014-02-04 11:57:02

Largest-ever study of 20-year survival among pediatric low-grade glioma patients highlights radiation's association with higher mortality The first comprehensive, large-scale cohort study of the long-term survival of children treated for low-grade gliomas, the most common pediatric brain tumor, finds that almost 90 percent are alive 20 years later and that few die from the tumor as adults. However, children who received radiation as part of their treatment had significantly lower long-term...

2014-01-24 13:27:45

Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient's tumor is likely to behave and which of several possible treatments is most likely to be effective. Reporting in the journal Cell Reports, researchers combined several types of data from pre- and post-treatment biopsies of breast tumors to obtain a molecular picture of how the cancer evolved as a result of chemotherapy. "Better understanding of tumor evolution is key to improving the...

2013-12-16 08:20:30

CEDAR PARK, Texas, Dec. 16, 2013 /PRNewswire/ -- Dana Holding Corporation (NYSE: DAN) announced today that the company has finalized plans to open its 16th global technology center in Cedar Park, Texas. Scheduled to begin operations in the spring of 2014, the center is designed to accommodate more than 80 engineers and support staff as part of an effort to fully leverage Dana's investment in its strategic relationship with Fallbrook Technologies, which is headquartered nearby. Dana...

2013-12-09 14:08:58

Bortezomib (Velcade) reduces GVHD, boosts survival Adding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem-cell transplants from mismatched and unrelated donors, according to researchers from Dana-Farber Cancer Institute. In a new phase 2 trial, patients treated with bortezomib had lower rates of severe acute GVHD and treatment-related mortality, and experienced better one-year overall...

2013-12-09 10:45:08

Patients with myelodysplastic syndromes (MDS) who were as old as 74 fared as well with stem cell transplantation as did patients in the 60-to-65 age range, according to a study from Dana-Farber Cancer Institute presented at the annual meeting of the American Society of Hematology. "This is good evidence that age alone should not limit who should get a transplant for MDS," said Gregory Abel, MD, MPH, a medical oncologist at Dana-Farber. "Calendar age is less important than other measures,...

2013-12-08 12:21:19

NEW ORLEANS, Dec. 8, 2013 /PRNewswire-USNewswire/ -- Several new, targeted therapies show promise to expand treatment options for chronic lymphocytic leukemia (CLL) and are more effective and better tolerated than standard chemotherapy, according to studies presented today during the 55th American Society of Hematology Annual Meeting and Exposition in New Orleans. CLL is a blood cancer that occurs when abnormal white blood cells called lymphocytes accumulate in the blood, bone...


Latest Dana Reference Libraries

10_882dd38af9cdeb8842ce7e31c378113c2
2004-10-19 04:45:44

Perseus Constellation -- Location: Northern Hemisphere; Coordinates: Right Ascension: 03h; Declination: +45; Source: Greek Mythology Perseus was the son of the Greek god Zeus and the mortal princess Danae. Perseus' grandfather, Acrisius, the king of Argos, was warned by an oracle that he would be killed by his grandson. Acrisius locked his daughter Danae in a dungeon to prevent her bearing a child. Zeus found a way into her dungeon disguised as a shower of gold. When the child Perseus...

More Articles (1 articles) »